You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Details for New Drug Application (NDA): 020701


✉ Email this page to a colleague

« Back to Dashboard


NDA 020701 describes CRINONE, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the CRINONE profile page.

The generic ingredient in CRINONE is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the progesterone profile page.
Summary for 020701
Tradename:CRINONE
Applicant:Allergan
Ingredient:progesterone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020701
Medical Subject Heading (MeSH) Categories for 020701
Suppliers and Packaging for NDA: 020701
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CRINONE progesterone GEL;VAGINAL 020701 NDA Allergan, Inc. 0023-6150 0023-6150-04 6 APPLICATOR in 1 CARTON (0023-6150-04) / 1.125 g in 1 APPLICATOR
CRINONE progesterone GEL;VAGINAL 020701 NDA Allergan, Inc. 0023-6151 0023-6151-08 15 APPLICATOR in 1 CARTON (0023-6151-08) / 1.125 g in 1 APPLICATOR

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;VAGINALStrength4%
Approval Date:Jul 31, 1997TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:GEL;VAGINALStrength8%
Approval Date:Jul 31, 1997TE:RLD:Yes

Expired US Patents for NDA 020701

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan CRINONE progesterone GEL;VAGINAL 020701-002 Jul 31, 1997 ⤷  Try a Trial ⤷  Try a Trial
Allergan CRINONE progesterone GEL;VAGINAL 020701-002 Jul 31, 1997 ⤷  Try a Trial ⤷  Try a Trial
Allergan CRINONE progesterone GEL;VAGINAL 020701-001 Jul 31, 1997 ⤷  Try a Trial ⤷  Try a Trial
Allergan CRINONE progesterone GEL;VAGINAL 020701-001 Jul 31, 1997 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.